Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Assets Average (2019 - 2025)

Bioadaptives' Assets Average history spans 7 years, with the latest figure at $175130.5 for Q4 2025.

  • Quarterly results put Assets Average at $175130.5 for Q4 2025, up 13.62% from a year ago — trailing twelve months through Dec 2025 was $175130.5 (up 13.62% YoY), and the annual figure for FY2025 was $243893.0, up 33.32%.
  • Assets Average for Q4 2025 was $175130.5 at Bioadaptives, down from $198437.5 in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $216650.0 in Q4 2023 to a low of $25176.5 in Q1 2023.
  • The 5-year median for Assets Average is $123386.5 (2021), against an average of $115426.8.
  • The sharpest move saw Assets Average tumbled 85.4% in 2024, then skyrocketed 619.92% in 2025.
  • Year by year, Assets Average stood at $163640.0 in 2021, then crashed by 79.55% to $33464.5 in 2022, then soared by 547.4% to $216650.0 in 2023, then decreased by 28.85% to $154139.0 in 2024, then grew by 13.62% to $175130.5 in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $175130.5, $198437.5, and $191481.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.